Hangzhou, China

Li Teng

This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Teng. Retrieved from https://idiyas.com/inventor/li-teng-qadgo4i0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Li Teng

Introduction

Li Teng is a prominent inventor based in Hangzhou, China. He has made significant strides in the field of pharmaceuticals, particularly with his innovative work on GLP-1/GIP dual agonists. His contributions have the potential to impact the treatment of various metabolic disorders.

Latest Patents

Li Teng holds a patent for a GLP-1/GIP dual agonist, which includes the preparation method and its uses. This patent showcases his expertise and commitment to advancing medical science. He has 1 patent to his name, reflecting his innovative approach to pharmaceutical development.

Career Highlights

Li Teng is currently employed at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. His role at the company allows him to collaborate with other talented professionals in the field. His work is characterized by a focus on developing effective treatments that can improve patient outcomes.

Collaborations

Li Teng has worked alongside notable colleagues such as Nan Zhang and Chunhua Jiang. Their combined efforts contribute to the innovative environment at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.

Conclusion

Li Teng's contributions to the field of pharmaceuticals through his patent on GLP-1/GIP dual agonists highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…